StartNHIQ • OTCMKTS
add
NantHealth Inc
Seneste lukkekurs
0,00010 $
Dagsinterval
0,00010 $ - 0,00010 $
Markedsværdi
2,75 t USD
Gns. volumen
187,00
P/E-værdi
-
Udbytteprocent
-
Primær børs
OTCMKTS
Markedsnyheder
Økonomi
Resultatopgørelse
Indtægt
Nettoindtægt
| (USD) | sep. 2023info | År til år-ændring |
|---|---|---|
Indtægt | 12,47 mio. | — |
Driftsudgifter | 12,17 mio. | — |
Nettoindtægt | -14,99 mio. | — |
Overskudsgrad | -120,20 | — |
Earnings per share | — | — |
EBITDA | -175,00 t | — |
Effektiv afgiftssats | -0,36 % | — |
Årsbalance
Samlede aktiver
Samlede passiver
| (USD) | sep. 2023info | År til år-ændring |
|---|---|---|
Kontanter og korttidsinvesteringer | 5,82 mio. | — |
Samlede aktiver | 146,48 mio. | — |
Samlede passiver | 396,66 mio. | — |
Samlet egenkapital | -250,18 mio. | — |
Shares outstanding | 27,47 mio. | — |
Kurs/indre værdi | -0,00 | — |
Afkast af aktiver | -8,24 % | — |
Afkast af kapital | -41,68 % | — |
Pengestrøm
Nettoændring i likviditet
| (USD) | sep. 2023info | År til år-ændring |
|---|---|---|
Nettoindtægt | -14,99 mio. | — |
Pengestrøm fra drift | -7,65 mio. | — |
Pengestrøm fra investering | 11,00 t | — |
Pengestrøm fra finansiering | 7,50 mio. | — |
Nettoændring i likviditet | -298,00 t | — |
Fri pengestrøm | -3,94 mio. | — |
Om
NantHealth, Inc. is a provider of software solutions for the healthcare industry, including NaviNet for insurance companies and decision support systems targeted at healthcare. The publicly traded company is headquartered in Winterville, North Carolina.
The company was founded by Patrick Soon-Shiong. His investment portfolio NantWorks controlled 62% of the voting shares of NantHealth at the end of 2021. Other notable early investors included Allscripts, BlackBerry, Kuwait Investment Authority, Celgene, and Verizon.
In September 2014, NantHealth was featured as the cover story in Forbes Magazine, which estimated NantHealth's market capitalization at $1.6 billion. In December 2014, NantHealth was featured on 60 Minutes by Sanjay Gupta. In August 2017, NantHealth signed a distribution agreement for GPS Cancer with Asia Genomics.
In January 2019, NantHealth received a delisting warning from Nasdaq "because the Company’s common stock failed to maintain a minimum closing bid price of $1.00 for 30 consecutive business days." At the time, the market value of the company was approximately $57m. The company made a 1-for-15 reverse stock split in December, 2022. Wikipedia
Administrerende direktør
Grundlagt
7. jul. 2010
Website
Ansatte
373
